News

The judge said a 2022 law that prevented pharmacists from contacting patients about the efficacy of ivermectin and ...
A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...
Participants with ongoing long-COVID symptoms were more likely to report any productivity loss in the preceding 3 months ...
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...
San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...
New recommendations from the National Academies of Sciences, Engineering, and Medicine are asking scientists to dive into ...
India's health statistics in 2021, including excess deaths, HDI rise, and improved mortality rates, analyzed and discussed ...
From the anti-vaccine movement and COVID denialism to the promotion of raw pet food, the wellness-industrial complex has ...
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis ...
DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Phase 2b Trial of Halneuron® in CINP underway; Interim Results ...
Expanding access to PrEP is a national public health challenge. But Mississippi is the farthest behind the rest of the ...
The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...